🇺🇸 Refresh Endura in United States

22 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 22

Most-reported reactions

1. Fall — 3 reports (13.64%)
2. Nausea — 3 reports (13.64%)
3. Abdominal Hernia — 2 reports (9.09%)
4. Aphonia — 2 reports (9.09%)
5. Arthralgia — 2 reports (9.09%)
6. Asthma — 2 reports (9.09%)
7. Blood Pressure Diastolic Decreased — 2 reports (9.09%)
8. Chest Discomfort — 2 reports (9.09%)
9. Chronic Obstructive Pulmonary Disease — 2 reports (9.09%)
10. Cough — 2 reports (9.09%)

Source database →

Frequently asked questions

Is Refresh Endura approved in United States?

Refresh Endura does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Refresh Endura in United States?

Federal University of São Paulo is the originator. The local marketing authorisation holder may differ — check the official source linked above.